In Mexico, cancer has become a significant health crisis, with recent statistics from Inegi revealing that over 95,000 deaths from malignant tumors were reported in 2024. This figure accounts for 11.5% of total deaths in the country, positioning cancer as the third leading cause of mortality, with breast cancer being the most prevalent among women and prostate cancer among men. The figures underscore an alarming trend in the country's public health scenario and indicate a growing need for effective intervention and prevention strategies.

The Pan American Health Organization has projected that one in five individuals will receive a cancer diagnosis in their lifetime, highlighting the pressing nature of this health issue. Outcomes for cancer patients, whether positive or negative, largely depend on the quality of healthcare available to them, which varies significantly across socioeconomic divides. Access to timely and appropriate treatment is crucial, especially given the prevalence of insurance gaps that many face in Mexico's healthcare system.

Economically, the burden of cancer extends beyond treatment costs, which can be up to four times higher for individuals without public health insurance. The Centro de Investigación Económica y Presupuestaria (CIEP) has pointed out that cancer treatment imposes significant financial strain not only on patients but also on their families, compounded by the unseen costs such as loss of income and emotional distress. The interplay of health and economics in this crisis necessitates a comprehensive approach to address both the medical and socioeconomic challenges posed by cancer in Mexico.